Invega 6 Janssen-Cilag
€109.00
Description
Description of Invega 6 Janssen-Cilag, product characteristics
Invega 6, produced by Janssen-Cilag, is an atypical antipsychotic medication primarily used in the treatment of schizophrenia and schizoaffective disorder. Its chemical composition is based on paliperidone, a metabolite of risperidone, and belongs to a class of drugs known for their effectiveness in managing symptoms of psychosis. Invega 6 offers advantages such as a once-daily dosing schedule that enhances medication adherence among patients. The formulation is designed for controlled release, ensuring consistent therapeutic levels throughout the day.
One of the defining features of Invega 6 is its affinity for various neurotransmitter receptors in the brain, including dopamine and serotonin receptors. This action helps to stabilize mood and reduce symptoms associated with mental health disorders. The drug has been extensively studied, demonstrating both efficacy and safety in its approved uses, making it a valuable asset in psychiatric treatment.
Effect on endurance, results of use
While Invega 6 is primarily prescribed for psychiatric conditions, some athletes and individuals involved in competitive sports have reported off-label use due to its potential impact on endurance and overall performance. The effects of paliperidone on endurance can be multifaceted. Some athletes believe that managing underlying mental health conditions can indirectly boost their physical performance, as improved mental clarity and reduced anxiety contribute to enhanced focus during training and competitions.
However, the results of using Invega 6 for endurance purposes can vary significantly. It is crucial to note that there is limited research on the direct impact of this medication on physical performance, and its primary formulation is geared towards psychiatric applications rather than athletic enhancement.
- Improved cognitive function in athletes with mental health issues.
- Indirect enhancement of endurance through better anxiety management.
- Potential for reduced fatigue due to stable mood levels.
Athletes should approach the use of Invega 6 with caution and consult with healthcare professionals to understand how it may affect their unique situations and performance goals.
Side effects, maximum safe dosage
Similar to other atypical antipsychotics, Invega 6 can have side effects that may vary based on individual responses. Common side effects include weight gain, drowsiness, and gastrointestinal disturbances. While many of these side effects are manageable, athletes need to be aware of their potential impact on performance and training regimens.
The maximum safe dosage of Invega for adults typically varies according to specific medical guidelines and patient needs. It is critical for individuals to follow a healthcare provider’s direction closely. For most adults, the usual starting dose may be 6 mg once daily, with adjustments as needed based on therapeutic response and tolerability. Increasing the dosage beyond the prescribed limit can lead to severe side effects and complications, emphasizing the importance of medical supervision.
Where to buy Invega 6 Janssen-Cilag, official store in English
Invega 6 Janssen-Cilag can be obtained through licensed pharmacies and healthcare providers. To ensure authenticity, it is advisable to purchase from official and reputable sources. Patients can check hospital pharmacy services or large chain pharmacies that offer prescription fulfillment. Online pharmacies may also provide convenience, but it is critical to select only those that require valid prescriptions and are certified.
For more information, it is best to visit Janssen-Cilag’s official website or consult a healthcare professional to locate designated pharmacies. This helps to avoid counterfeit products and ensures that customers receive genuine medications with necessary guidance.
Practical recommendations
When considering the use of Invega 6 for any purpose, including its potential effects on sports performance, certain recommendations should be followed:
- Consult with a healthcare professional before starting any medication.
- Monitor mental health and performance closely; document any changes.
- Adhere strictly to prescribed dosages to mitigate the risk of side effects.
- Combine treatment with a balanced approach to nutrition, hydration, and rest.
- Stay aware of your body’s responses and discuss any concerns immediately with a healthcare provider.
These practical recommendations ensure that athletes can maintain both mental well-being and optimal performance while considering the use of Invega 6 Janssen-Cilag.
Additional information
| Active substance | Paliperidone |
|---|---|
| Classification | Antipsychotic |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring plasma levels not typically required but may be performed to ensure therapeutic levels |
| Also known as | Paliperidone |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Invega |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 9-hydroxyrisperidone |
| Formula | C23H27FN4O3 |
| Substance class | Atypical antipsychotic |
| Main action | Antagonist of serotonin type 2 (5HT2) and dopamine type 2 (D2) receptors |
| Half-life | Approximately 23 hours |
| Dosage (medical) | Typically starts at 3 mg per day, can be adjusted up to 12 mg per day based on clinical response |
| Dosage (sports) | Not applicable |
| Effects | Symptom reduction in schizophrenia and schizoaffective disorder |
| Side effects | Extrapyramidal symptoms (EPS), tachycardia, weight gain, dizziness, insomnia, constipation |
| Use in sports | None |
| Manufacturer | Janssen-Cilag |




Reviews
There are no reviews yet.